Overview Financials News + Filings Key Docs Charts Ownership Insiders |
TECUMSEH PRODUCTS CO (TECU)
|
Add to portfolio |
|
|
Price: |
$6.85
| | Metrics |
OS: |
18.6
|
M
| |
-11
|
% ROE
|
Market cap: |
$127
|
M
| |
-4
|
% ROIC
|
Net debt:
|
$32.4
|
M
| |
2.6
|
x Debt/EBITDA
|
EV:
|
$160
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$12.7
|
M
| |
12.6
|
x EV/EBITDA
|
EBIT
|
($9.2)
|
M
| |
|
|
EPS |
($0.71)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
Revenues | 724.4 | 823.6 | 854.7 | 864.4 | 933.8 | 735.9 | 996.4 | 1,136.1 |
Revenue growth | -12.0% | -3.6% | -1.1% | -7.4% | 26.9% | -26.1% | -12.3% | 13.3% |
Cost of goods sold | 653.7 | 745.5 | 790.0 | 826.5 | 849.5 | 687.6 | 891.3 | 1,001.4 |
Gross profit | 70.7 | 78.1 | 64.7 | 37.9 | 84.3 | 48.3 | 105.1 | 134.7 |
Gross margin | 9.8% | 9.5% | 7.6% | 4.4% | 9.0% | 6.6% | 10.5% | 11.9% |
Selling, general and administrative | 92.2 | 104.9 | 107.7 | 108.1 | 114.1 | 125.2 | 129.6 | 131.8 |
EBIT | -21.0 | -19.0 | 19.9 | -64.0 | -65.8 | -69.5 | -68.3 | 2.9 |
EBIT margin | -2.9% | -2.3% | 2.3% | -7.4% | -7.0% | -9.4% | -6.9% | 0.3% |
Pre-tax income | -27.8 | -26.7 | 12.9 | -72.2 | -75.2 | -102.4 | -83.0 | -13.2 |
Income taxes | 0.5 | 7.7 | -10.2 | -0.9 | -16.6 | -10.6 | -5.0 | -8.2 |
Tax rate | | | | 1.2% | 22.1% | 10.4% | 6.0% | 62.1% |
Earnings from continuing ops | -28.3 | -34.4 | 23.1 | -71.3 | -58.6 | -91.8 | -78.0 | -5.0 |
Earnings from discontinued ops | | | | | | | 27.5 | -173.1 |
Net income | -32.7 | -37.5 | 22.6 | -73.2 | -56.8 | -93.4 | -50.5 | -178.1 |
Net margin | -4.5% | -4.6% | 2.6% | -8.5% | -6.1% | -12.7% | -5.1% | -15.7% |
|
Diluted EPS | ($1.53) | ($1.86) | $1.25 | ($3.86) | ($3.17) | ($4.97) | ($4.22) | ($270.56) |
Shares outstanding (diluted) | 18.5 | 18.5 | 18.5 | 18.5 | 18.5 | 18.5 | 18.5 | 0.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|